Filter Results:
(260)
Show Results For
- All HBS Web
(260)
- News (29)
- Research (197)
- Multimedia (2)
- Faculty Publications (101)
Show Results For
- All HBS Web
(260)
- News (29)
- Research (197)
- Multimedia (2)
- Faculty Publications (101)
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details
- May 2002 (Revised October 2005)
- Case
Marketing Antidepressants: Prozac and Paxil
By: Youngme E. Moon and Kerry Herman
Describes the marketing of Prozac and Paxil, two of the best-selling mental health drugs in history. Set in 2001, several months before the expiration of Prozac's patent, Eli Lilly (Prozac's manufacturer) and GlaxoSmithKline (Paxil's manufacturer) must decide how to... View Details
Keywords: Patents; Product Positioning; Competition; Ethics; Value; Health Care and Treatment; Brands and Branding; Pharmaceutical Industry; United States
Moon, Youngme E., and Kerry Herman. "Marketing Antidepressants: Prozac and Paxil." Harvard Business School Case 502-055, May 2002. (Revised October 2005.)
- September 2010
- Teaching Note
Alnylam Pharmaceuticals: Building Value from the IP Estate (TN)
By: Willy C. Shih
Teaching Note for 611009. View Details
- October 1992 (Revised September 1993)
- Case
Nopane Advertising Strategy
By: David E. Bell
Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details
Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States
Bell, David E. "Nopane Advertising Strategy." Harvard Business School Case 893-005, October 1992. (Revised September 1993.)
- 20 May 2013
- Op-Ed
Making America an Industrial Powerhouse Again
competitive global economy, US manufacturing can thrive only if it is at the leading edge of knowledge. History provides some guidelines for making sure the NNMI lives up to its potential: Have a broad agenda: Government-funded research... View Details
- 01 Dec 2003
- News
The Next Big Thing
It's a case of competition and strategy on a global scale, and the stakes could hardly be higher. The prize? Leadership in the realm of life sciences, a field that experts say will shape and dominate 21st-century enterprise. What city or... View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
Casadesus-Masanell and Andres Hervas-Drane Abstract We study competitive interaction between two alternative models of digital content distribution over the Internet: peer-to-peer (p2p) file sharing and centralized client-server... View Details
Keywords: Sean Silverthorne
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
Source: Cecilie_Arcurs George Serafeim has a startling suggestion to fix the world’s biggest environmental, social, and governance (ESG) problems such as water pollution, deforestation, and wealth inequality: encourage companies within industries to do less competing... View Details
- 23 May 2000
- Research & Ideas
Minding the Muse: The Impact of Downsizing on Corporate Creativity
pharmaceutical firms that rely on creativity," she says. "Today's fast-changing global markets place increased pressure on companies of every kind to continuously create new products, services, and View Details
Keywords: by Peter K. Jacobs
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
Growth," followed four tracks of inquiry: managing innovation, information technology and competitive strategy, transforming the enterprise, and entrepreneurship. "Ours is an era of organizational experimentation," observed Professor Gary... View Details
- Web
Souvenirs & Novelties - The Art of American Advertising
Clubs Faculty & Research Business & Environment Business History Christensen Center for Teaching & Learning Entrepreneurship Faculty & Research Global Healthcare HBS Working Knowledge Institute for Strategy & Competitiveness Leadership... View Details
- 07 Aug 2009
- What Do You Think?
Why Can’t Americans Get Health Care Right?
above are numerous in a channel that includes, in your comments, food and tobacco producers of unhealthy products (Christy Hitchens, Tom Dolembo); lifestyle equipment and service providers; developers and manufacturers of high-cost View Details
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
excelled at analog photography but hasn't been able to make the leap to digital cameras. Boeing, a longtime leader in commercial aircraft, has experienced difficulties in its defense-contracting businesses and has recently stumbled in the face of View Details
- 28 Mar 2023
- Blog Post
Novo Nordisk
learned details of how Novo Nordisk manufactures within its 1,200,000 square meter facility high-quality active pharmaceutical ingredients (APIs) that tackle not only diabetes but also hemophilia, growth disorders, and obesity. At their... View Details
- March 1999 (Revised June 2000)
- Case
Eli Lilly: The Evista Project
By: Steven C. Wheelwright and Matt Verlinden
Describes the creation and operation of the initial two heavyweight teams for new drug development and launch. The primary focus is on one of the teams, Evista, although comparisons to the other team, Zyprexa, are included. Lilly must decide the next phase (postlaunch)... View Details
Keywords: Projects; Groups and Teams; Operations; Management Teams; Product Development; Transition; Product Design; Business Startups; Business Plan; Product Launch; Competition; Service Operations; Pharmaceutical Industry
Wheelwright, Steven C., and Matt Verlinden. "Eli Lilly: The Evista Project." Harvard Business School Case 699-016, March 1999. (Revised June 2000.)
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
what are some of the possible negative consequences of remaining stagnant? Stefan Thomke: Competitive environments and technologies are constantly changing, which creates both wonderful opportunities to innovate and grave threats if we... View Details
Keywords: by Wendy Guild
- 05 Jan 2011
- Op-Ed
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress
for years to come. Unpredictability inflicts a heavy cost on scientific progress, whether in domains like stem-cell research or in searching for safe alternative fuels. It damages the United States' competitive position because great... View Details
- 02 Oct 2000
- Research & Ideas
The Dubious Logic of Global Megamergers
with their mega-deals, you can exploit that fact to improve your own competitive position. For instance, while pharmaceutical players such as Glaxo Wellcome and SmithKline Beecham have made headlines with... View Details
Keywords: by Pankaj Ghemawat & Fariborz Ghadar
- 06 Mar 2012
- First Look
First Look: March 6
residential real estate and away from more productive investments. Third, the cost of professional investment management is too high, which drains talent from other industries. The financial sector could promote the health and View Details
Keywords: Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
policy debate. Positive aggregate productivity gains are often attributed to within-firm productivity improvement; however, an alternative, less emphasized explanation is between-firm selection and market reallocation, whereby competition... View Details
Keywords: Sean Silverthorne